Suppr超能文献

在泌乳细胞上鉴定出一种与腺苷酸环化酶无关的D1多巴胺受体。

Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.

作者信息

Schoors D F, Vauquelin G P, De Vos H, Smets G, Velkeniers B, Vanhaelst L, Dupont A G

机构信息

Department of Pharmacology, Medical School, Vrije Universiteit Brussel V.U.B., Belgium.

出版信息

Br J Pharmacol. 1991 Aug;103(4):1928-34. doi: 10.1111/j.1476-5381.1991.tb12354.x.

Abstract
  1. We studied the lactotroph cells of the rat by both in vivo and in vitro pharmacological techniques for the presence of D1-receptors. Both approaches revealed the presence of D2-receptor, stimulated by quinpirole (resulting in an inhibition of prolactin secretion) and blocked by domperidone. 2. Administration of fenoldopam, the most selective D1-receptor agonist currently available, resulted in a dose-dependent decrease of prolactin secretion in vivo (after pretreatment with alpha-methyl-p-tyrosine) and in vitro (cultured pituitary cells). This increase was dose-dependently blocked by the selective D1-receptor antagonist, SCH 23390, and although the effect of fenoldopam was less than that obtained by D2-receptor stimulation, these data suggest that a D1-receptor also controls prolactin secretion. 3. In order to detect the location of these dopamine receptors, autoradiographic studies were performed by use of [3H]-SCH 23390 and [3H]-spiperone as markers for D1- and D2-receptors, respectively. Specific binding sites for [3H]-SCH 23390 were demonstrated. Fenoldopam dose-dependently reduced [3H]-SCH 23390 binding, but had no effect on [3H]-spiperone binding. Immunocytochemical labelling of prolactin cells after incubation with [3H]-SCH 23390 revealed that the granulae and hence, D1 binding sites were present on the lactotroph cells. 4. Radioligand binding studies performed on membranes from anterior pituitary cells revealed the presence of the D2-receptor (54 fmol mg-1 protein) with a Kd of 0.58 nM for [3H]-spiperone, but failed to detect D1-receptors. 5. Finally, we studied the effect of dopamine and of fenoldopam on the adenosine 3':5'-cyclic monophosphate (cyclic AMP) content of anterior pituitary cells. Although cyclic AMP increased upon prostacyclin administration, indicating an intact adenylate cyclase system, fenoldopam failed to increase the cyclic AMP production. 6. It is tempting to speculate that fenoldopam reduces prolactin secretion through interaction with a non-cyclase-linked D1-receptor on the lactotroph cells.
摘要
  1. 我们通过体内和体外药理学技术研究大鼠的催乳素细胞中是否存在D1受体。两种方法均显示存在D2受体,喹吡罗可刺激该受体(导致催乳素分泌受到抑制),多潘立酮可阻断该受体。2. 给予目前可得的最具选择性的D1受体激动剂非诺多泮,可使体内(用α-甲基-p-酪氨酸预处理后)和体外(培养的垂体细胞)的催乳素分泌呈剂量依赖性降低。这种增加被选择性D1受体拮抗剂SCH 23390剂量依赖性地阻断,尽管非诺多泮的作用小于D2受体刺激所获得的作用,但这些数据表明D1受体也控制催乳素分泌。3. 为了检测这些多巴胺受体的位置,分别使用[3H]-SCH 23390和[3H]-螺哌隆作为D1和D2受体的标记物进行放射自显影研究。证实了[3H]-SCH 23390的特异性结合位点。非诺多泮剂量依赖性地降低[3H]-SCH 23390的结合,但对[3H]-螺哌隆的结合无影响。用[3H]-SCH 23390孵育后对催乳素细胞进行免疫细胞化学标记显示,颗粒以及因此的D1结合位点存在于催乳素细胞上。4. 对垂体前叶细胞膜进行的放射性配体结合研究显示存在D2受体(54 fmol mg-1蛋白质),对于[3H]-螺哌隆的Kd为0.58 nM,但未检测到D1受体。5. 最后,我们研究了多巴胺和非诺多泮对垂体前叶细胞中腺苷3':5'-环磷酸(环磷酸腺苷)含量的影响。尽管给予前列环素后环磷酸腺苷增加,表明腺苷酸环化酶系统完整,但非诺多泮未能增加环磷酸腺苷的产生。6. 很容易推测非诺多泮通过与催乳素细胞上的非环化酶连接的D1受体相互作用来降低催乳素分泌。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e714/1908193/72e2c82c57f1/brjpharm00238-0101-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验